IRIS PubliCatt

Chiusolo, Patrizia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.253
EU - Europa 5.868
AS - Asia 1.549
OC - Oceania 107
AF - Africa 80
SA - Sud America 54
Continente sconosciuto - Info sul continente non disponibili 7
Totale 13.918
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.150
DE - Germania 2.000
SE - Svezia 1.037
CN - Cina 897
IT - Italia 865
UA - Ucraina 384
IE - Irlanda 309
GB - Regno Unito 304
FR - Francia 297
SG - Singapore 259
RU - Federazione Russa 147
IN - India 144
FI - Finlandia 135
PL - Polonia 124
AU - Australia 98
CA - Canada 80
TR - Turchia 62
CI - Costa d'Avorio 54
BE - Belgio 36
NL - Olanda 35
BR - Brasile 28
JP - Giappone 28
CZ - Repubblica Ceca 26
HK - Hong Kong 24
IR - Iran 24
ES - Italia 21
AT - Austria 20
RO - Romania 19
VN - Vietnam 19
MX - Messico 16
TH - Thailandia 13
CH - Svizzera 12
HU - Ungheria 12
ID - Indonesia 12
KR - Corea 12
PT - Portogallo 12
NO - Norvegia 11
SA - Arabia Saudita 10
CL - Cile 9
DZ - Algeria 9
GR - Grecia 9
NZ - Nuova Zelanda 9
IL - Israele 8
AR - Argentina 7
EG - Egitto 7
SK - Slovacchia (Repubblica Slovacca) 7
HR - Croazia 6
CO - Colombia 5
EE - Estonia 5
LB - Libano 5
MY - Malesia 5
NP - Nepal 5
RS - Serbia 5
TW - Taiwan 5
AE - Emirati Arabi Uniti 4
BA - Bosnia-Erzegovina 4
BG - Bulgaria 4
BZ - Belize 4
DK - Danimarca 4
EU - Europa 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BY - Bielorussia 3
GH - Ghana 3
MD - Moldavia 3
MK - Macedonia 3
PE - Perù 3
BD - Bangladesh 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
IS - Islanda 2
JO - Giordania 2
LI - Liechtenstein 2
MA - Marocco 2
UY - Uruguay 2
IQ - Iraq 1
KE - Kenya 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MC - Monaco 1
MM - Myanmar 1
MT - Malta 1
PA - Panama 1
PH - Filippine 1
PK - Pakistan 1
QA - Qatar 1
SC - Seychelles 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 13.918
Salva come PNG Salva come JPEG
Città #
Chandler 1.057
Ashburn 445
Dublin 304
Jacksonville 294
Dearborn 243
San Mateo 227
Nanjing 178
Ann Arbor 169
Milan 166
Houston 160
Wilmington 158
Beijing 144
Singapore 144
Rome 124
Woodbridge 116
New York 114
Nürnberg 114
Fairfield 113
Boston 111
Moscow 108
Redwood City 106
Warsaw 106
Seattle 101
Los Angeles 97
Lancaster 91
Cattolica 89
Nanchang 84
Marseille 81
Princeton 81
Bremen 71
Lawrence 68
Chicago 55
Abidjan 54
Florence 53
Munich 51
Redmond 51
Izmir 49
Kunming 46
Boardman 44
Cambridge 33
Helsinki 33
Tianjin 33
Brussels 32
Norwalk 32
Shanghai 30
Shenyang 30
Guangzhou 29
Pune 29
Leawood 28
Hangzhou 27
Changsha 26
Hefei 26
Mountain View 25
Zhengzhou 25
San Francisco 24
Hebei 23
Auburn Hills 22
Brno 22
London 22
Washington 22
Jiaxing 21
Adelaide 20
Toronto 20
Hong Kong 19
Brisbane 18
Phoenix 18
Hanoi 16
Philadelphia 16
University Park 16
Augusta 15
Melbourne 15
Brooklyn 14
Lappeenranta 14
Portland 14
San Diego 14
Buffalo 12
Santa Clara 11
Sydney 11
Bangkok 10
Changchun 10
Falls Church 10
Fremont 10
Lanzhou 10
Seoul 10
Vienna 10
Amsterdam 9
Atlanta 9
Hermosillo 9
Kyoto 9
Mumbai 9
North Hollywood 9
Berlin 8
Bologna 8
Lebanon 8
Nuremberg 8
Simi Valley 8
Tokyo 8
Traverse City 8
Arezzo 7
Canberra 7
Totale 6.918
Salva come PNG Salva come JPEG
Nome #
VITAMIN B12 DEFICIENCY: CORRELATION BETWEEN MTHFR POLYMORPHISMS AND CLINICAL AND LABORATORY FINDINGS 1.989
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 349
Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: An open-label, multicentre, randomised, phase 3 trial 305
Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis 301
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 223
Salivary proteomic analysis and acute graft versus host disease after allogeneic hematopoietic stem cell transplantation 162
Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease. 145
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 141
Correlation between paraproteinaemia and viral reactivation after allo-SCT 135
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 132
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 130
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 130
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 129
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 129
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 128
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 125
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 123
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis 121
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 120
Prospective evaluation of Epstein-Barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 118
Prognostic implications of additional genomic lesions in adult Philadelphia chromosome-positive acute lymphoblastic leukemia 117
Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre-transplant therapy 113
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 112
Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipients 112
Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia 111
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab. 111
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 110
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication 105
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 104
Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms 102
Role of 18F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients. 102
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 102
AB0 type does not affect platelet engraftment after autologous peripheral blood stem cell transplant in a series of 249 hematologic patients 101
EXTREME THROMBOCYTOSIS IN CHRONIC MYELOID LEUKEMIA IN THE ERA OF TYROSINE KINASE INHIBITORS 101
Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration 100
Prospective evaluation of epstein-barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 99
Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia 99
Role of (18)F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients 98
Work related acute leukemia and mucor mycosis in a boat-builder 97
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 97
Hyperleukocytosis and leukostasis: management of a medical emergency 97
Bone marrow megakaryocytic activation predicts fibrotic evolution of Philadelphia-negative myeloproliferative neoplasms 97
Retrospective comparison of qualitative and quantitative reverse transcriptase polymerase chain reaction in diagnosing and monitoring the ALL1-AF4 fusion transcript in patients with acute lymphoblastic leukaemia. 96
Hyperleukocytosis and leukostasis: management of a medical emergency 96
Role of fecal calprotectin as biomarker of gastrointestinal GVHD after allogeneic stem cell transplantation 95
H1N1 Influenza among Hematological Patients: Monocentric Influenza Cases from 2011 to 2016 94
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 93
Neurologic improvement after peripheral blood stem cell transplantation in poems 93
Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms 92
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue 91
Allogeneic cord blood transfusions prevent fetal haemoglobin depletion in preterm neonates. Results of the CB-TrIP study 91
Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease 89
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 89
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 88
JAK2 V617F mutational frequency in essential thrombocythemia associated with splanchnic or cerebral vein thrombosis 87
Non-tunnelled central venous catheters in adult stem cell transplantation recipients: an effective option 86
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 85
Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population 83
MTHFR polymorphisms involved in vitamin B12 deficiency associated with atrophic gastritis 83
Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial 82
Granulocyte transfusions as adjunctive treatment of invasive fungal diseases in neutropenic patients 81
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 80
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 79
High-dose glucocorticoids plus Ofatumumab in fludarabine/alemtuzumab-resistant B-cell chronic lymphocytic leukemia 77
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 77
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 76
Negative prognostic value of glutathione s-transferase (gstm1 and gstt1) deletions in adult acute myeloid leukemia. 74
Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy 74
Fecal but not serum calprotectin is a potential marker of GVHD after stem cell transplantation. 73
UGT1A1 Polymorphism and Mortality Outcome after Allogeneic Stem Cell Transplantation with Busulfan Based Regimen 72
Allogeneic Hemopoietic Stem Cell Transplants in Patients with Acute Myeloid Leukemia (AML) Prepared with Busulfan and Fludarabine (BUFLU) or Thiotepa, Busulfan, and Fludarabine (TBF): A Retrospective Study 69
Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers 68
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 68
Changes in protein serum levels during stem cell transplantation 66
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 66
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 66
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 65
Incidence and Outcome of Invasive Fungal Diseases after Allogeneic Stem Cell Transplantation: A Prospective Study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) 63
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide :does graft cell content have an impact on main clinical outcomes? 63
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 62
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 62
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients 62
Unrelated cord blood transplantation and post-transplant cyclophosphamide 61
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 61
Extracorporeal Photopheresis for Treatment of Acute and Chronic Graft Versus Host Disease: An Italian Multicentric Retrospective Analysis on 94 Patients on Behalf of the Gruppo Italiano Trapianto di Midollo Osseo 60
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 60
Inline and offline extracorporeal photopheresis: Device performance, cell yields and clinical response 60
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 59
Unrelated cord blood transplantation and post-transplant cyclophosphamide 59
Allogeneic hematopoietic stem cell transplantation in therapy-related myeloid neoplasms (t-MN) of the adult: Monocentric observational study and review of the literature 59
Coronavirus disease 2019 pandemic and allogeneic hematopoietic stem cell transplantation: a single center reappraisal 58
Mononuclear cell collection for extracorporeal photopheresis: Concentrate characteristics for off-line UV-A irradiation procedure 57
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 56
Extracorporeal Photopheresis for Treatment of Acute and Chronic Graft Versus Host Disease: An Italian Multicentric Retrospective Analysis on 94 Patients on Behalf of the Gruppo Italiano Trapianto di Midollo Osseo 56
Autologous peripheral blood stem cell transplantation and the role of lenalidomide in patients affected by poems syndrome 55
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide: does graft cell content have an impact on main clinical outcomes? 55
Pre-Exposure to Defibrotide Prevents Endothelial Cell Activation by Lipopolysaccharide: An Ingenuity Pathway Analysis 55
ABO Mismatch in Allogeneic Hematopoietic Stem Cell Transplant: Effect on Short- And Long-term Outcomes 55
Allogeneic Transplant for Mycosis Fungoides in Patient with Wiskott-Aldrich Syndrome 54
Preoperative autologous blood donation in adult bone marrow donors: reappraisal of a single-centre experience 54
Totale 11.612
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.089
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.089
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.792 0 175 173 147 203 236 199 96 122 166 156 119
2020/20211.252 81 116 81 96 111 101 114 32 151 60 265 44
2021/20221.549 150 91 43 70 104 39 35 219 90 127 261 320
2022/20233.213 435 436 243 475 226 378 182 241 316 89 134 58
2023/20242.666 84 450 125 172 150 302 162 115 105 259 367 375
2024/2025469 358 111 0 0 0 0 0 0 0 0 0 0
Totale 14.259